Long-Term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-Severe Dementia Associated With Parkinson's Disease (PDD)

This study is ongoing, but not recruiting participants.

Study NCT00623103 Information provided by Novartis

First Received: February 14, 2008 Last Updated: July 8, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	October 2010 (Final data collection date for primary outcome measure)